Tropical spastic paraparesis primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Tropical spastic paraparesis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{CMG}} =...") |
m (Changes made per Mahshid's request) |
||
(One intermediate revision by one other user not shown) | |||
Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Blood transfusion products are screened for [[HTLV-1]] antibodies. | |||
==References== | ==References== | ||
Line 13: | Line 14: | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] |
Latest revision as of 19:02, 18 September 2017
Tropical spastic paraparesis Microchapters |
Differentiating Tropical spastic paraparesis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Tropical spastic paraparesis primary prevention On the Web |
American Roentgen Ray Society Images of Tropical spastic paraparesis primary prevention |
Directions to Hospitals Treating Tropical spastic paraparesis |
Risk calculators and risk factors for Tropical spastic paraparesis primary prevention |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Blood transfusion products are screened for HTLV-1 antibodies.